Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

NCT03013933 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Hodgkin Lymphoma
Refractory Hodgkin Lymphoma

Interventions

DRUG: Brentuximab Vedotin
DRUG: Cyclosporine
OTHER: Pharmacokinetic Study
DRUG: Verapamil
DRUG: Verapamil Hydrochloride

Sponsor

City of Hope Medical Center

Collaborators

[object Object]